Medi Biotek (India) Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
- Paid Up Capital ₹ 0.10 M
- Company Age 14 Year, 18 Days
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 3.28 Cr
- Revenue Growth -55.60%
- Profit Growth -69.11%
- Ebitda -17.40%
- Net Worth 8.21%
- Total Assets -15.71%
About Medi Biotek (India)
Medi Biotek (India) Private Limited (MBIPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 14 January 2011 and has a history of 14 years. Its registered office is in Chennai, Tamil Nadu, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹3.28 Cr.
Jayantilal, Rajat Jain, Dulichand Jain, and One other member serve as directors at the Company.
Company Details
-
Location
Chennai, Tamil Nadu, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U33125TN2011PTC078832
-
Company No.
078832
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
14 Jan 2011
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Chennai
Industry
What products or services does Medi Biotek (India) Private Limited offer?
Medi Biotek (India) Private Limited offers a wide range of products and services, including Medical Laboratory Instruments, Pathology Lab Equipments, Biochemistry Analyzer, Hand Sanitizers & Personal Hygiene, Hand Sanitizer & Disinfectant, Surgical & ICU Equipments, Ventilator, Orthopedic Equipment & Supplies, Orthopedic Instruments, IVDs & Analyzers.
Who are the key members and board of directors at Medi Biotek (India)?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shrapi Singhvi
|
Director | 21-Feb-2020 | Current |
|
Jayantilal
|
Director | 14-Jan-2011 | Current |
|
Rajat Jain
|
Director | 03-Jan-2012 | Current |
|
Dulichand Jain
|
Director | 09-Aug-2023 | Current |
Financial Performance of Medi Biotek (India).
Medi Biotek (India) Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 55.6% decrease. The company also saw a substantial fall in profitability, with a 69.11% decrease in profit. The company's net worth moved up by a moderate rise of 8.21%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Medi Biotek (India)?
In 2023, Medi Biotek (India) had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Mc Medibio Life Science Private LimitedJayantilal and Rajat Jain are mutual person
-
Modern Circus Private LimitedShrapi Singhvi is a mutual person
-
Maa-Dees Concepts LlpShrapi Singhvi is a mutual person
Charges (Loans)
₹32.79 M
₹0
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 3.28 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 23 Nov 2020 | Hdfc Bank Limited | ₹1.50 M | Open |
| 25 Apr 2019 | Hdfc Bank Limited | ₹3.13 Cr | Open |
How Many Employees Work at Medi Biotek (India)?
Unlock and access historical data on people associated with Medi Biotek (India), such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Medi Biotek (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Medi Biotek (India)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
